Omeros Corp. (OMER) Jumps: Stock Rises 18.1%

Zacks Equity Research

Omeros Corporation (OMER) was a big mover last session, as the company saw its shares rise by over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $7.14 to $9.25.

This biopharmaceutical company has seen no estimate revision in the past one month but its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.

Omeros currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, some better -ranked medical products stocks include Boston Scientific Corporation (BSX), diaDexus, Inc. (DDXS) and Exactech Inc. (EXAC). All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

OMEROS CORP (OMER): Free Stock Analysis Report

BOSTON SCIENTIFIC CORP (BSX): Free Stock Analysis Report

DIADEXUS INC (DDXS): Free Stock Analysis Report

EXACTECH INC (EXAC): Free Stock Analysis Report

Zacks Investment Research